- Report
- October 2024
- 600 Pages
Global
From €1391EUR$1,400USD£1,156GBP
- Report
- October 2024
- 600 Pages
Global
From €1391EUR$1,400USD£1,156GBP
- Report
- September 2024
- 117 Pages
Global
From €3800EUR$3,825USD£3,160GBP
€4471EUR$4,500USD£3,717GBP
- Report
- June 2024
- 200 Pages
Global
From €5529EUR$5,565USD£4,597GBP
€7898EUR$7,950USD£6,567GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1391EUR$1,400USD£1,156GBP
€1987EUR$2,000USD£1,652GBP
- Report
- February 2024
- 25 Pages
Global
€17038EUR$17,150USD£14,166GBP
- Report
- November 2023
- 190 Pages
Global
From €4918EUR$4,950USD£4,089GBP
- Report
- November 2023
- 110 Pages
Global
From €2931EUR$2,950USD£2,437GBP
- Report
- July 2024
- 59 Pages
Asia Pacific
From €2931EUR$2,950USD£2,437GBP
- Report
- June 2024
- 67 Pages
Europe
From €2931EUR$2,950USD£2,437GBP
- Report
- June 2024
- 180 Pages
United States
From €5911EUR$5,950USD£4,915GBP
- Report
- October 2024
- 124 Pages
Europe
From €4918EUR$4,950USD£4,089GBP
- Report
- February 2024
- 114 Pages
Middle East, Africa
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- February 2024
- 125 Pages
Asia Pacific
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- February 2024
- 126 Pages
Europe
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- February 2024
- 109 Pages
North America
From €2469EUR$2,485USD£2,053GBP
€3527EUR$3,550USD£2,932GBP
- Report
- July 2024
- 139 Pages
United States
From €3675EUR$3,699USD£3,055GBP
- Report
- February 2024
- 70 Pages
United States
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 90 Pages
United States
From €4719EUR$4,750USD£3,924GBP
- Report
- February 2024
- 160 Pages
Middle East, Africa
From €4719EUR$4,750USD£3,924GBP
The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders.
Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists.
Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more